Elske H.
- Country
- The Netherlands
- Department
- Neurology
Research Overview
- Noisy Rebels; Non-inferiority study of rituximab compared to ocrelizumab in relapsing MS
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Personalized B Cell-Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 32 of 219 partner sites.
Specializations
Multiple Sclerosis Research
This investigator specializes in advancing treatment approaches for multiple sclerosis, with particular emphasis on progressive forms of MS and innovative therapeutic strategies.
- Progressive Multiple Sclerosis Treatment
- Brain Atrophy Assessment
- Quantitative MRI Analysis
The research focuses on evaluating novel therapeutic compounds and their effects on disease progression.
Personalized Medicine
The investigator explores personalized treatment approaches in multiple sclerosis therapy, focusing on individualized dosing strategies and treatment intervals.
- B-cell Targeted Therapies
- Extended Interval Dosing
- Treatment Optimization
Research emphasizes tailoring treatment schedules to individual patient responses.
Comparative Treatment Studies
The investigator conducts research comparing different therapeutic approaches for multiple sclerosis, with particular interest in anti-CD20 therapies.
- Treatment Efficacy Assessment
- Safety Validation
- Real-life Clinical Applications
Studies focus on establishing treatment equivalence and optimizing therapeutic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.